In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Alessandra VirgaBiosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0001-9427-3875 Flavia FocaUnit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0002-5529-4769 Stefania CortecchiaAzienda Unità Sanitaria Locale (AUSL) Imola, 40026 Imola, Italy.
Francesca PoliAzienda Unità Sanitaria Locale (AUSL) Imola, 40026 Imola, Italy.
Paola CaroliNuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
Federica MatteucciNuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0001-7455-6253 Roberta MaltoniDepartment of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0003-0366-792X Massimiliano MazzaBiosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0001-9053-5743 Fabio NicoliniBiosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0001-6846-5435 Paola UliviBiosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0002-4334-9662 Giovanni PaganelliNuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0002-2631-4652 Maurizio PuccettiAzienda Unità Sanitaria Locale (AUSL) Imola, 40026 Imola, Italy.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
breast cancerKi67 and PSMA PET/CTPSMA expressiontheranostic biomarkerTILs
Identifiers
PMID41898275
PMCPMC13024703
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390